Ixabepilone alone or with cetuximab as first-line treatment for advanced/metastatic triple-negative breast cancer.
Trédan O, Campone M, Jassem J, Vyzula R, Coudert B, Pacilio C, Prausova J, Hardy-Bessard AC, Arance A, Mukhopadhyay P, Aloe A, Roché H.
Trédan O, et al. Among authors: vyzula r.
Clin Breast Cancer. 2015 Feb;15(1):8-15. doi: 10.1016/j.clbc.2014.07.007. Epub 2014 Aug 15.
Clin Breast Cancer. 2015.
PMID: 25218708
Clinical Trial.